Business Standard

Both Serum's Covishield, Bharat Bio's Covaxin vaccines cost same to Centre

People can't choose between Covishield & Covaxin, says govt; vaccine to take effect two weeks after the second dose

serum institute, coronavirus, covid, vaccine, pharma
Premium

The government is paying Rs 231 crore for Covishield while it is shelling out around Rs 162 crore for Covaxin

Ruchika ChitravanshiSohini Das
The Centre has bought the first lot of the two approved vaccines — Serum Institute’s Covishield and Bharat Biotech’s Covaxin — at nearly the same price. The 1.65 million free doses of Covaxin being supplied to the government bring down the effective cost of procuring 5.5 million vaccines from Bharat Biotech to Rs 206 per dose (without taxes).

Moreover, people will not have the option of choosing between the two vaccines, Union Health Secretary Rajesh Bhushan clarified on Tuesday. “Many countries in the world are using multiple vaccines. There is no such option available in any country,” Bhushan said.

The Centre has

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in